Trade Mark Journal No.2025/021 23 May 2025

WO0000001852794 (5,42,44)

Office of origin: United States of America

Date of International Registration:20 March 2025
Date of designation in the UK: 20 March 2025
Image for mark 1852794 ENCENTRIO

International priority date claimed: 2 October 2024 (United States of America) (98782884)
Class 5
Pharmaceutical and biological preparations and medicinal infusions for prevention and treatment of infectious diseases and disorders, viral diseases and disorders, and in the field of oncology.
Class 42
Research and development in the pharmaceutical and biotechnology fields; development of pharmaceutical preparations and medicines; pharmaceutical, biomedical, biological therapeutic research services; research in the field of pharmaceutical and biologic therapeutic preparations; pharmaceutical research and development; providing scientific research information in the field of pharmaceuticals, biomedicine, clinical trials, and post-market trials.
Class 44
Providing health and medical information; providing information relating to the diagnostic, prophylactic and therapeutic properties of pharmaceutical preparations and biologic preparations for the prevention and treatment of diseases, disorders, and conditions; medical and pharmaceutical consultation.

Vir Biotechnology, Inc.

Representative: Amanda B. Agati Fross Zelnick Lehrman & Zissu, P.C., 151 West 42nd Street, New York NY 10036, UNITED STATES OF AMERICA